Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03554733 · ClinicalTrials.gov registry record · NA

Bridge Reinvention

A NA study of Spinal Cord Injuries, sponsored by Craig Hospital.

Completed
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT03554733 is a NA study of Spinal Cord Injuries that has completed, run by Craig Hospital. The registered enrollment target is 46 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03554733, a NA study of Spinal Cord Injuries, has completed, sponsored by Craig Hospital.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

The goal of this randomized controlled trial is to determine the efficacy of a treatment to improve resilience to stress for individuals with SCI who are transitioning from inpatient rehabilitation to home. The overarching hypothesis is that individuals who participate in an intervention that presents positive psychotherapy topics in an interactive, structured, cognitive-behaviorally-based group intervention that stresses restructuring maladaptive thought processes and provides experiential opportunities to reinforce behavioral change will demonstrate increased self-efficacy.

Conditions Studied

Interventions

  • BEHAVIORAL ReInventing Yourself after SCI

Study Locations (1)

Colorado

  • Craig Hospital - Englewood

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2014-04-01
Est. Completion 2018-04-30
Phase NA

Sponsor

Craig Hospital

29 total trials

What the Registry Record Tells You About NCT03554733

The ClinicalTrials.gov registry entry for NCT03554733 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (25% lower). The listed sponsor is Craig Hospital, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which ReInventing Yourself after SCI is the first listed.

NCT03554733 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT03554733 about?

NCT03554733 is a clinical study titled "Bridge Reinvention". The goal of this randomized controlled trial is to determine the efficacy of a treatment to improve resilience to stress for individuals with SCI who are transitioning from inpatient rehabilitation to home. The overarching hypothesis is that individuals who participate in an intervention that presen...

What is the current status of trial NCT03554733?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2014-04-01. Estimated completion is 2018-04-30.

What conditions does trial NCT03554733 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT03554733?

The interventions under investigation include: ReInventing Yourself after SCI (BEHAVIORAL).

Who is sponsoring clinical trial NCT03554733?

This trial is sponsored by Craig Hospital, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03554733 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.